Page 197 - Aet News Today

Insignia has exited its 45% stake in JANA as it progresses its simplification and transformation strategy, detailed in its quarterly results.

Atomic AI combines artificial intelligence analysis with wet lab experiments to discover small molecules capable of drugging RNA. The startup, based on technology initially developed at Stanford, is backed by a $35 million Series A round of financing.

I have 127 million followers that continues to grow rapidly, suggesting i am reasonably popular. i might not be popular by some people, but for the vast majority of people, my follow count speaks for itself. twitter is an incredibly powerful tool for driving demand for tesla. d0 powerful tool for driving demand for tesla. do you think ou aet demand for tesla. do you think you get another— demand for tesla. do you think you get another tesla? - demand for tesla. do you think you get another tes...

Tia — a startup providing hybrid primary care, OB/GYN services and mental health care to women — is now partnered with Cedars-Sinai in addition to UCSF Health and CommonSpirit Health. Under Tia's partnership model, the company combines its primary care with health systems' specialty care to reduce fragmentation and advance preventive health.

Digital health's investment slowdown is so severe that the fourth quarter of 2022 marked the lowest quarterly digital health funding total in the past five years, according to new report. Q4 was also the first quarter with no new unicorn births since 2018.

Covering travel expenses is not an act of altruism for employers. It's in their financial interest to have their workforce access the specialized care they need to feel better rather than consigning them to an inadequate care treadmill at the local hospital.

Wisdo, a social health platform that addresses loneliness and social isolation, teamed up with Humana to serve some of its Medicare Advantage members. A new study on Humana's members found that 58% of participants reported lower rates of loneliness after three months of using Wisdo's app.

Astellas has become an active player in gene therapy. MedCity News caught up with company executive Richard Wilson, who explained Astellas’s strategy, the clinical holds on its two most advanced programs, and the rationale behind its recent gene therapy deals.

Check out executive hires from SnapNurse, Almaden Genomics, Dr. Evidence, Healthy.io, Wheel, and Sage Bionetworks.

Amazon's RxPass offers more than 50 generic drugs for more than 80 common conditions at the flat fee of $5 a month for Prime members. While one expert says its a significant move by Amazon, another said more needs to be done.